Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · IEX Real-Time Price · USD
0.883
-0.057 (-6.06%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Hoth Therapeutics Market Cap
Hoth Therapeutics has a market cap or net worth of $4.73 million as of July 2, 2024. Its market cap has decreased by -53.15% in one year.
Market Cap
4.73M
Enterprise Value
-2.78M
1-Year Change
-53.15%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since February 15, 2019, Hoth Therapeutics's market cap has decreased from $80.40M to $4.73M, a decrease of -94.11%. That is a compound annual growth rate of -40.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 4.30M | -31.75% |
| Dec 29, 2023 | 6.30M | -37.62% |
| Dec 30, 2022 | 10.10M | -36.08% |
| Dec 31, 2021 | 15.80M | -50.31% |
| Dec 31, 2020 | 31.80M | -49.20% |
| Dec 31, 2019 | 62.60M | -22.14% |
| Feb 15, 2019 | 80.40M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TFF Pharmaceuticals | 5.14M |
| Titan Pharmaceuticals | 5.09M |
| Synaptogenix | 5.06M |
| Venus Concept | 4.97M |
| Leafly Holdings | 4.95M |
| Adial Pharmaceuticals | 4.87M |
| Enveric Biosciences | 4.85M |
| Bright Minds Biosciences | 4.84M |